To include your compound in the COVID-19 Resource Center, submit it here.

RG7334: Phase Ib/II started

Roche began a Phase Ib/II trial to evaluate RG7334 plus Avastin bevacizumab in about 100

Read the full 155 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE